INDICAL BIOSCIENCE, operating under the mission "Improving diagnostics for better animal and human health," is a standalone entity continuing the legacy of its predecessor, QIAGEN's veterinary business. With over three decades of expertise, INDICAL specializes in providing comprehensive molecular diagnostic workflows, which include sample prep kits, assays, reagents, and instruments. These are strategically designed to aid veterinarians, industry players, and government bodies globally.
Founded in 2018 and headquartered in Germany, INDICAL has positioned itself prominently in Biotechnology, Health Care, and Life Sciences industries. The company stands at the forefront of animal and human health diagnostics, leveraging its profound experience to deliver advanced solutions that address crucial health challenges. Despite no recorded last investment, the company's renewed focus and independent status signify a robust platform for potential growth and partnerships in the diagnostics landscape.